# Transanal Versus Laparoscopic Total Mesorectal Excision For Rectal Cancer

> **NCT03359616** · NA · UNKNOWN · sponsor: **Shanghai Minimally Invasive Surgery Center** · enrollment: 258 (estimated)

## Conditions studied

- Rectal Cancer
- Surgery

## Interventions

- **PROCEDURE:** Transanally curable surgical resection
- **PROCEDURE:** Laparoscopic total mesorectal excision

## Key facts

- **NCT ID:** NCT03359616
- **Lead sponsor:** Shanghai Minimally Invasive Surgery Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01-01
- **Primary completion:** 2021-01-01
- **Final completion:** 2022-01-01
- **Target enrollment:** 258 (ESTIMATED)
- **Last updated:** 2017-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03359616

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03359616, "Transanal Versus Laparoscopic Total Mesorectal Excision For Rectal Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03359616. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*